You may qualify and be compensated up to $2,500 if you meet the following requirements:
Study duration: 18 days maximum with 1 screening day, 1 overnight stay, 1 dosing day, and 3 outpatient visits.
Study objective: The study drug (eye drops T4090) is intended to reduce Intra-Ocular Pressure (IOP) in adult patients. This clinical trial will evaluate the study drug's safety and systemic plasma concentration in healthy participants.
For more information, contact our recruiters at 844-246-8459 or email us at email@example.com
What is glaucoma? Intra-Ocular Pressure (IOP) can damage the optic nerve and lead to glaucoma and vision loss. Glaucoma is one of the leading causes of irreversible blindness on a global scale. In the US, the prevalence of glaucoma is predicted to go from 2.7 million in 2010 to 6.3 million in 2050.
Share this study:
Become a medical research volunteer and help find a treatment, vaccine, or cure for diseases.
Complete the registration form and call us at 844-246-8459. Our recruiters will be happy to help you, and it will take 5 minutes of your time to know if you are eligible. Your information will be kept strictly confidential.